Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Principal Shareholder Yield Index ETF | PY | Nov 22, 2024 | 51.93 | +0.70 |
Principal U.S. Small Cap Index ETF | PSC | Nov 22, 2024 | 55.65 | +1.66 |
Priority Income Fund | PRIF-L | Nov 22, 2024 | 23.88 | -0.29 |
Priority Income Fund | PRIF-K | Nov 22, 2024 | 22.26 | 0.00 |
Priority Income Fund D Pref | PRIF-D | Nov 22, 2024 | 24.36 | +0.87 |
Priority Income Fund F Pref | PRIF-F | Nov 22, 2024 | 24.65 | +1.63 |
Priority Income Fund G Pref | PRIF-G | Nov 22, 2024 | 25.04 | +2.58 |
Priority Income Fund I Pref | PRIF-I | Nov 22, 2024 | 23.50 | 0.00 |
Priority Income Fund J Pref | PRIF-J | Nov 22, 2024 | 23.56 | -0.21 |
Priority Income Fund Pref | PRIF-H | Nov 22, 2024 | 24.25 | +1.14 |
Priority Technology | PRTH | Nov 22, 2024 | 8.02 | -3.95 |
Privia Health Group | PRVA | Nov 22, 2024 | 21.56 | +2.28 |
Pro-Dex | PDEX | Nov 22, 2024 | 46.75 | +10.44 |
ProAssurance | PRA | Nov 22, 2024 | 16.64 | +0.54 |
Procaps Group | PROC | Nov 22, 2024 | 0.92 | -17.12 |
Procept BioRobotics | PRCT | Nov 22, 2024 | 93.60 | -0.90 |
Processa Pharmaceuticals | PCSA | Nov 22, 2024 | 0.86 | -2.26 |
Procore Technologies | PCOR | Nov 22, 2024 | 76.68 | +1.93 |
Procter & Gamble | PG | Nov 22, 2024 | 176.28 | +2.04 |
Professional Diversity Network | IPDN | Nov 22, 2024 | 0.80 | +6.97 |
Proficient Auto Logistics | PAL | Nov 22, 2024 | 9.80 | +2.73 |
Profire Energy | PFIE | Nov 22, 2024 | 2.52 | 0.00 |
Profound Medical | PROF | Nov 22, 2024 | 7.55 | +0.40 |
ProFrac A | ACDC | Nov 22, 2024 | 7.75 | +2.65 |
PROG | PRG | Nov 22, 2024 | 47.43 | +2.35 |
Progress Software | PRGS | Nov 22, 2024 | 69.25 | +0.76 |
Progressive | PGR | Nov 22, 2024 | 266.06 | +0.99 |
Progyny | PGNY | Nov 22, 2024 | 15.44 | +3.14 |
ProKidney | PROK | Nov 22, 2024 | 1.69 | -2.87 |
Prologis | PLD | Nov 22, 2024 | 115.80 | +1.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.